The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management

University Medical Center Groningen70 enrolled

Overview

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Palliative Medicine

Interventions

SurveyOTHER

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate: * General practice * Nursing home * Hospital: * Clinical geriatrics * Medical oncology * Radiation oncology * Pulmonology * Cardiology Exclusion Criteria: HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation. GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Locations (2)

University Medical Center Groningen

Groningen, Netherlands

LUMC

Leiden, Netherlands

Outcomes

Primary Outcomes

Questions evaluating Intention to Use (IU)

Questions evaluating Intention to Use (IU) (7-point Likert scales)

Time frame: after 5 times use of the MuSt-PC tool within 3 months

Secondary Outcomes

Questions evaluating other modified TAM domains

Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).

Time frame: after 5 times use of the MuSt-PC tool within 3 months

Perceived benefits and disadvantages of using MuSt-PC

Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).

Time frame: after 5 times use within 3 months

Suggestions to improve the MuSt-PC CDSS

Suggestions to improve the MuSt-PC CDSS (open-ended question).

Time frame: after 5 times of the MuSt-PC tool within 3 months

An overview of the content of questions of participating GHCPs regarding MuSt-PC use.

An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).

Time frame: after 5 times use within 3 months

Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.

Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.